What does Chromadex Corp. do?

Jun 22 2025 06:40 PM IST
share
Share Via
Chromadex Corporation is a nutraceutical company in the Pharmaceuticals & Biotechnology industry, focusing on research and quality-control products for the natural products sector. As of March 2025, it reported net sales of $30 million and a net profit of $5 million, with a market cap of approximately $1.09 billion.
Overview:
Chromadex Corporation is an integrated nutraceutical company operating in the Pharmaceuticals & Biotechnology industry, focusing on research and quality-control products and services for the natural products sector. Financial Snapshot: Most recent Net Sales: 30 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 5 Million (Quarterly Results - Mar 2025) Market cap: USD 1,093.32 Million (Micro Cap) Key Metrics: P/E: 63.00 Dividend Yield: 0.00% Debt Equity: -0.99 Return on Equity: 29.28% Price to Book: 19.75 Contact Details: Address: 10900 Wilshire Blvd Ste 600, LOS ANGELES CA: 90024-6534 Tel: ['1 310 3886706', '1 949 4190288'] Fax: 1 302 6583694 Website: https://chromadex.com/default.aspx
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News